Healthcare provider profile · identity verified

Anna C Maio, MD

Internal Medicine · OMAHA, NE · NPI 1871684126

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	434	119
Levothyroxine Sodium	Levothyroxine Sodium	434	102
Amlodipine Besylate	Amlodipine Besylate	341	93
Omeprazole	Omeprazole	253	65
Metoprolol Succinate	Metoprolol Succinate	212	50
Simvastatin	Simvastatin	204	52
Losartan Potassium	Losartan Potassium	187	53
Lisinopril	Lisinopril	184	51
Meloxicam	Meloxicam	180	39
Trazodone Hcl	Trazodone Hcl	177	37
Gabapentin	Gabapentin	147	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	34
Pantoprazole Sodium	Pantoprazole Sodium	133	34
Alprazolam	Alprazolam	128	27
Tramadol Hcl	Tramadol Hcl	118	32
Lorazepam	Lorazepam	113	20
Escitalopram Oxalate	Escitalopram Oxalate	110	25
Potassium Chloride	Potassium Chloride	110	26
Zolpidem Tartrate	Zolpidem Tartrate	109	15
Albuterol Sulfate Hfa	Albuterol Sulfate	108	28
Duloxetine Hcl	Duloxetine Hcl	108	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	102	15
Montelukast Sodium	Montelukast Sodium	99	25
Alendronate Sodium	Alendronate Sodium	95	29
Hydrochlorothiazide	Hydrochlorothiazide	93	31
Sertraline Hcl	Sertraline Hcl	91	21
Metformin Hcl Er	Metformin Hcl	88	25
Metoprolol Tartrate	Metoprolol Tartrate	87	22
Ozempic	Semaglutide	85	11
Fluticasone Propionate	Fluticasone Propionate	83	19
Donepezil Hcl	Donepezil Hcl	80	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	21
Furosemide	Furosemide	78	24
Rosuvastatin Calcium	Rosuvastatin Calcium	77	25
Eliquis	Apixaban	75	15
Fluoxetine Hcl	Fluoxetine Hcl	74	13
Metformin Hcl	Metformin Hcl	67	19
Carvedilol	Carvedilol	64	13
Atenolol	Atenolol	62	12
Famotidine	Famotidine	62	16
Memantine Hcl	Memantine Hcl	56	suppressed
Pregabalin	Pregabalin	50	11
Olmesartan Medoxomil	Olmesartan Medoxomil	47	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	47	11
Tamsulosin Hcl	Tamsulosin Hcl	47	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Pravastatin Sodium	Pravastatin Sodium	45	14
Venlafaxine Hcl Er	Venlafaxine Hcl	42	12
Bupropion Xl	Bupropion Hcl	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Mirtazapine	Mirtazapine	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Clonazepam	Clonazepam	39	suppressed
Symbicort	Budesonide/Formoterol Fumarate	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Myrbetriq	Mirabegron	38	suppressed
Spironolactone	Spironolactone	37	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Prednisone	Prednisone	34	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Fluconazole	Fluconazole	31	13
Mounjaro	Tirzepatide	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Azithromycin	Azithromycin	29	24
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Premarin	Estrogens, Conjugated	29	suppressed
Estradiol	Estradiol	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Loperamide	Loperamide Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Cefdinir	Cefdinir	23	16
Liothyronine Sodium	Liothyronine Sodium	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Olanzapine	Olanzapine	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Diazepam	Diazepam	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Valsartan	Valsartan	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Cephalexin	Cephalexin	15	12
Januvia	Sitagliptin Phosphate	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Zafirlukast	Zafirlukast	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error